Blood Flow Measurement Devices Market by Product (Ultrasound (Transit Time Flow Meter), Laser Doppler), Application (Invasive (CABG, Microvascular Surgery), Non-invasive (Cardiovascular, Gastroenterology & Tumor Monitoring)) - Global Forecast to 2021
The blood flow measurement devices market is projected to reach USD 533.0 million by 2021 from USD 343.6 million in 2016, growing at a CAGR of 9.2% in the next five years (2016 to 2021).
The growth of the overall blood flow measurement devices market can be contributed to the growing prevalence of cardiovascular diseases and diabetes coupled with rising geriatric population, the influx of VC funding, and technological advancements. However, the dearth of skilled professionals is limiting the growth of the global blood flow measurement devices market.
The global blood flow measurement devices market is segmented on the basis of product, application, and region. In 2016, North America accounted for the largest share of the global blood flow measurement devices market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). Asia-Pacific is projected to have the highest growth rate in the forecast period. Factors such as the growing focus of industry players in the region, increasing geriatric population, and growing prevalence of non-communicable diseases are likely to propel the market in the Asia-Pacific region.
The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (product launches, product extensions, product enhancements; collaborations/agreements/partnerships/joint ventures/contracts, fund, technology development, patent, and expansions) to increase their market shares and establish a strong foothold in the global market.
In-depth interviews were conducted with CEOs, Sales and Marketing Directors, other innovation and technology directors, and executives from various key organizations operating in the adaptive security market place.
REASONS TO BUY THE REPORT:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
The growth of the overall blood flow measurement devices market can be contributed to the growing prevalence of cardiovascular diseases and diabetes coupled with rising geriatric population, the influx of VC funding, and technological advancements. However, the dearth of skilled professionals is limiting the growth of the global blood flow measurement devices market.
The global blood flow measurement devices market is segmented on the basis of product, application, and region. In 2016, North America accounted for the largest share of the global blood flow measurement devices market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). Asia-Pacific is projected to have the highest growth rate in the forecast period. Factors such as the growing focus of industry players in the region, increasing geriatric population, and growing prevalence of non-communicable diseases are likely to propel the market in the Asia-Pacific region.
The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (product launches, product extensions, product enhancements; collaborations/agreements/partnerships/joint ventures/contracts, fund, technology development, patent, and expansions) to increase their market shares and establish a strong foothold in the global market.
In-depth interviews were conducted with CEOs, Sales and Marketing Directors, other innovation and technology directors, and executives from various key organizations operating in the adaptive security market place.
- By Company Type: Tier 1: 50%, Tier 2: 42%, Tier 3: 8%
- By Designation: Director Level: 58%, C-level: 25%, Others: 17%
- By Region: North America: 46%, Europe: 31%, APAC: 15%, RoW: 8%
REASONS TO BUY THE REPORT:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the products offered by top players in the blood flow measurement devices market. The report analyzes the blood flow measurement devices by product and application
- Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the blood flow measurement devices market
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for blood flow measurement devices across regions
- Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the blood flow measurement devices market
- Competitive Assessment: In-depth assessment of market shares, strategies, products, and distribution networks of the leading players in the blood flow measurement devices market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH METHODOLOGY STEPS
2.1.1 SECONDARY AND PRIMARY RESEARCH METHODOLOGY
2.1.1.1 Secondary research
2.1.1.2 Primary research
2.2 MARKET SIZE ESTIMATION METHODOLOGY
2.3 MARKET FORECAST METHODOLOGY
2.4 MARKET DATA VALIDATION AND TRIANGULATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 BLOOD FLOW MEASUREMENT DEVICES: MARKET OVERVIEW
4.2 REGIONAL SNAPSHOT: BLOOD FLOW MEASUREMENT DEVICES MARKET,
BY PRODUCT (2016)
4.3 GLOBAL BLOOD FLOW MEASUREMENT DEVICES MARKET, BY APPLICATION,
2016 VS. 2021 (USD MILLION)
4.4 GEOGRAPHIC SNAPSHOT OF THE GLOBAL BLOOD FLOW MEASUREMENT
DEVICES MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing prevalence of cardiovascular disease and diabetes, coupled with rising geriatric population
5.2.1.2 Technological advancements
5.2.1.3 Influx of VC funding
5.2.2 RESTRAINTS
5.2.2.1 Development of alternative methods to treat cardiovascular diseases is restraining market growth for transit-time flow meters
5.2.3 OPPORTUNITIES
5.2.3.1 Highly unpenetrated market for transit-time blood flow meters
5.2.3.2 Emerging markets across India and China
5.2.4 CHALLENGES
5.2.4.1 Dearth of skilled professionals
6 BLOOD FLOW MEASUREMENT DEVICES MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 ULTRASOUND
6.2.1 ULTRASOUND DOPPLER
6.2.2 TRANSIT-TIME FLOW METERS
6.3 LASER DOPPLER
7 BLOOD FLOW MEASUREMENT DEVICES MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 NON-INVASIVE APPLICATIONS
7.2.1 CARDIOVASCULAR DISEASE
7.2.2 DIABETES
7.2.3 GASTROENTEROLOGY
7.2.4 TUMOR MONITORING
7.2.5 OTHER NON-INVASIVE APPLICATIONS
7.3 INVASIVE APPLICATIONS
7.3.1 CABG
7.3.2 MICROVASCULAR SURGERY
7.3.3 OTHER INVASIVE APPLICATIONS
8 BLOOD FLOW MEASUREMENT DEVICES MARKET, BY REGION
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 U.S.
8.2.1.1 Rapidly growing geriatric population and subsequent increase
in the prevalence of cardiovascular diseases
8.2.1.2 Increasing prevalence of hypertension
8.2.1.3 Regulatory requirements coupled with a favorable reimbursement scenario
8.2.1.4 Increased funding for technological advancement
8.2.2 CANADA
8.2.2.1 Technological advances
8.2.2.2 Increasing number of organ transplant procedures
8.3 EUROPE
8.3.1 EUROPE-5
8.3.1.1 Growing focus of industry players
8.3.1.2 Increasing prevalence of cancer in Europe-5
8.3.2 REST OF EUROPE
8.3.2.1 High diabetes prevalence in european countries
8.4 ASIA-PACIFIC
8.4.1 GROWING FOCUS OF INDUSTRY PLAYERS
8.4.2 INCREASING GERIATRIC POPULATION AND SUBSEQUENT INCREASE IN INCIDENCES OF NONCOMMUNICABLE DISEASES IN ASIA-PACIFIC
8.4.3 FAVORABLE REIMBURSEMENT ENVIRONMENT IN JAPAN
8.5 REST OF THE WORLD
8.5.1 LATIN AMERICA
8.5.2 THE MIDDLE EAST
8.5.3 AFRICA
9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPARATIVE ASSESSMENT OF KEY PLAYERS IN THE BLOOD FLOW MEASUREMENT DEVICES MARKET (2013–2017)
9.3 COMPETITIVE SITUATION AND TRENDS
9.3.1 PRODUCT LAUNCHES, PRODUCT ENHANCEMENTS, AND PRODUCT EXTENSIONS
9.3.2 COLLABORATIONS, AGREEMENTS, CONTRACTS, JOINT VENTURES, AND PARTNERSHIPS
9.3.3 EXPANSIONS
9.3.4 OTHER STRATEGIES
10 COMPANY PROFILES
(OVERVIEW, PRODUCTS AND SERVICES, FINANCIALS, STRATEGY & DEVELOPMENT)*
10.1 INTRODUCTION
10.2 MEDISTIM ASA
10.3 COOK MEDICAL, INC.
10.4 GETINGE GROUP
10.5 DELTEX MEDICAL GROUP PLC
10.6 TRANSONIC SYSTEMS, INC.
10.7 COMPUMEDICS LIMITED
10.8 SONOTEC ULTRASCHALLSENSORIK HALLE GMBH
10.9 BIOPAC SYSTEMS INC.
10.10 MOOR INSTRUMENTS LTD.
10.11 ATYS MEDICAL
10.12 PERIMED AB
*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies
11 APPENDIX
11.1 DISCUSSION GUIDE
11.2 OTHER DEVELOPMENTS (2013–2016)
11.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
11.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
11.5 AVAILABLE CUSTOMIZATIONS
11.6 RELATED REPORTS
11.7 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH METHODOLOGY STEPS
2.1.1 SECONDARY AND PRIMARY RESEARCH METHODOLOGY
2.1.1.1 Secondary research
2.1.1.2 Primary research
2.2 MARKET SIZE ESTIMATION METHODOLOGY
2.3 MARKET FORECAST METHODOLOGY
2.4 MARKET DATA VALIDATION AND TRIANGULATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 BLOOD FLOW MEASUREMENT DEVICES: MARKET OVERVIEW
4.2 REGIONAL SNAPSHOT: BLOOD FLOW MEASUREMENT DEVICES MARKET,
BY PRODUCT (2016)
4.3 GLOBAL BLOOD FLOW MEASUREMENT DEVICES MARKET, BY APPLICATION,
2016 VS. 2021 (USD MILLION)
4.4 GEOGRAPHIC SNAPSHOT OF THE GLOBAL BLOOD FLOW MEASUREMENT
DEVICES MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing prevalence of cardiovascular disease and diabetes, coupled with rising geriatric population
5.2.1.2 Technological advancements
5.2.1.3 Influx of VC funding
5.2.2 RESTRAINTS
5.2.2.1 Development of alternative methods to treat cardiovascular diseases is restraining market growth for transit-time flow meters
5.2.3 OPPORTUNITIES
5.2.3.1 Highly unpenetrated market for transit-time blood flow meters
5.2.3.2 Emerging markets across India and China
5.2.4 CHALLENGES
5.2.4.1 Dearth of skilled professionals
6 BLOOD FLOW MEASUREMENT DEVICES MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 ULTRASOUND
6.2.1 ULTRASOUND DOPPLER
6.2.2 TRANSIT-TIME FLOW METERS
6.3 LASER DOPPLER
7 BLOOD FLOW MEASUREMENT DEVICES MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 NON-INVASIVE APPLICATIONS
7.2.1 CARDIOVASCULAR DISEASE
7.2.2 DIABETES
7.2.3 GASTROENTEROLOGY
7.2.4 TUMOR MONITORING
7.2.5 OTHER NON-INVASIVE APPLICATIONS
7.3 INVASIVE APPLICATIONS
7.3.1 CABG
7.3.2 MICROVASCULAR SURGERY
7.3.3 OTHER INVASIVE APPLICATIONS
8 BLOOD FLOW MEASUREMENT DEVICES MARKET, BY REGION
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 U.S.
8.2.1.1 Rapidly growing geriatric population and subsequent increase
in the prevalence of cardiovascular diseases
8.2.1.2 Increasing prevalence of hypertension
8.2.1.3 Regulatory requirements coupled with a favorable reimbursement scenario
8.2.1.4 Increased funding for technological advancement
8.2.2 CANADA
8.2.2.1 Technological advances
8.2.2.2 Increasing number of organ transplant procedures
8.3 EUROPE
8.3.1 EUROPE-5
8.3.1.1 Growing focus of industry players
8.3.1.2 Increasing prevalence of cancer in Europe-5
8.3.2 REST OF EUROPE
8.3.2.1 High diabetes prevalence in european countries
8.4 ASIA-PACIFIC
8.4.1 GROWING FOCUS OF INDUSTRY PLAYERS
8.4.2 INCREASING GERIATRIC POPULATION AND SUBSEQUENT INCREASE IN INCIDENCES OF NONCOMMUNICABLE DISEASES IN ASIA-PACIFIC
8.4.3 FAVORABLE REIMBURSEMENT ENVIRONMENT IN JAPAN
8.5 REST OF THE WORLD
8.5.1 LATIN AMERICA
8.5.2 THE MIDDLE EAST
8.5.3 AFRICA
9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPARATIVE ASSESSMENT OF KEY PLAYERS IN THE BLOOD FLOW MEASUREMENT DEVICES MARKET (2013–2017)
9.3 COMPETITIVE SITUATION AND TRENDS
9.3.1 PRODUCT LAUNCHES, PRODUCT ENHANCEMENTS, AND PRODUCT EXTENSIONS
9.3.2 COLLABORATIONS, AGREEMENTS, CONTRACTS, JOINT VENTURES, AND PARTNERSHIPS
9.3.3 EXPANSIONS
9.3.4 OTHER STRATEGIES
10 COMPANY PROFILES
(OVERVIEW, PRODUCTS AND SERVICES, FINANCIALS, STRATEGY & DEVELOPMENT)*
10.1 INTRODUCTION
10.2 MEDISTIM ASA
10.3 COOK MEDICAL, INC.
10.4 GETINGE GROUP
10.5 DELTEX MEDICAL GROUP PLC
10.6 TRANSONIC SYSTEMS, INC.
10.7 COMPUMEDICS LIMITED
10.8 SONOTEC ULTRASCHALLSENSORIK HALLE GMBH
10.9 BIOPAC SYSTEMS INC.
10.10 MOOR INSTRUMENTS LTD.
10.11 ATYS MEDICAL
10.12 PERIMED AB
*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies
11 APPENDIX
11.1 DISCUSSION GUIDE
11.2 OTHER DEVELOPMENTS (2013–2016)
11.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
11.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
11.5 AVAILABLE CUSTOMIZATIONS
11.6 RELATED REPORTS
11.7 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 COUNTRIES WITH THE HIGHEST MORTALITY RATE FROM PERIPHERAL VASCULAR DISEASE (2013)
TABLE 2 TOP 5 COUNTRIES WITH THE HIGHEST NUMBER OF DIABETICS (AGED 20–79 YEARS), 2015 VS. 2040
TABLE 3 INDICATIVE LIST OF COMPANIES THAT RECEIVED VENTURE CAPITALIST FUNDING FOR THE BLOOD FLOW MEASUREMENT AND MONITORING SEGMENT
TABLE 4 GLOBAL BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
TABLE 5 ULTRASOUND BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
TABLE 6 ULTRASOUND BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
TABLE 7 ULTRASOUND DOPPLER MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
TABLE 8 TRANSIT-TIME FLOW METERS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
TABLE 9 LASER DOPPLER BLOOD FLOW MEASURING DEVICES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
TABLE 10 GLOBAL BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
TABLE 11 BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR NON-INVASIVE APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION)
TABLE 12 BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR NON-INVASIVE APPLICATIONS, BY REGION, 2014–2021 (USD MILLION)
TABLE 13 CARDIOVASCULAR DISEASE APPLICATIONS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
TABLE 14 DIABETES APPLICATIONS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
TABLE 15 GASTROENTEROLOGY APPLICATIONS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
TABLE 16 TUMOR MONITORING APPLICATIONS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
TABLE 17 OTHER NON-INVASIVE APPLICATIONS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
TABLE 18 BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR INVASIVE APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION)
TABLE 19 BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR INVASIVE APPLICATIONS, BY REGION, 2014–2021 (USD MILLION)
TABLE 20 CABG SURGERY APPLICATIONS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
TABLE 21 MICROVASCULAR SURGERY APPLICATIONS MARKET, BY REGION, 2014–2021 (USD MILLION)
TABLE 22 OTHERS INVASIVE APPLICATIONS MARKET, BY REGION, 2014–2021 (USD MILLION)
TABLE 23 BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
TABLE 24 NORTH AMERICA: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
TABLE 25 NORTH AMERICA: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
TABLE 26 NORTH AMERICA: ULTRASOUND BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
TABLE 27 NORTH AMERICA: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
TABLE 28 NORTH AMERICA: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR NON-INVASIVE APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION)
TABLE 29 NORTH AMERICA: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR INVASIVE APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION)
TABLE 30 U.S.: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
TABLE 31 U.S.: ULTRASOUND BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
TABLE 32 U.S.: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
TABLE 33 U.S.: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR NON-INVASIVE APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION)
TABLE 34 U.S.: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR INVASIVE APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION)
TABLE 35 ORGAN TRANSPLANT PROCEDURES PERFORMED IN CANADA (2012–2014)
TABLE 36 CANADA: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
TABLE 37 CANADA: ULTRASOUND BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
TABLE 38 CANADA: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
TABLE 39 CANADA: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR NON-INVASIVE APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION)
TABLE 40 CANADA: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR INVASIVE APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION)
TABLE 41 EUROPE: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
TABLE 42 EUROPE: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
TABLE 43 EUROPE: ULTRASOUND BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
TABLE 44 EUROPE: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
TABLE 45 EUROPE: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR NON-INVASIVE APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION)
TABLE 46 EUROPE: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR INVASIVE APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION)
TABLE 47 EUROPE-5: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
TABLE 48 EUROPE-5: ULTRASOUND BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
TABLE 49 EUROPE-5: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
TABLE 50 EUROPE-5: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR NON-INVASIVE APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION)
TABLE 51 EUROPE-5: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR INVASIVE APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION)
TABLE 52 ROE: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
TABLE 53 ROE: ULTRASOUND BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
TABLE 54 ROE: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
TABLE 55 ROE: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR NON-INVASIVE APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION)
TABLE 56 ROE: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR INVASIVE APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION)
TABLE 57 ASIA-PACIFIC: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
TABLE 58 ASIA-PACIFIC: ULTRASOUND BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
TABLE 59 ASIA-PACIFIC: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
TABLE 60 ASIA-PACIFIC: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR
NON-INVASIVE APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION)
TABLE 61 ASIA-PACIFIC: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR INVASIVE APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION)
TABLE 62 ROW: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
TABLE 63 ROW: ULTRASOUND BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
TABLE 64 ROW: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
TABLE 65 ROW: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR NON-INVASIVE APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION)
TABLE 66 ROW: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR INVASIVE APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION)
TABLE 67 PRODUCT LAUNCHES, PRODUCT ENHANCEMENTS, AND PRODUCT EXTENSIONS, BY COMPANY (2013–2017)
TABLE 68 COLLABORATIONS, AGREEMENTS, CONTRACTS, JOINT VENTURES, AND PARTNERSHIPS, 2013–2017
TABLE 69 EXPANSIONS AND MARKET DEVELOPMENT (2013–2017)
TABLE 70 OTHER STRATEGIES (2013–2017)
TABLE 1 COUNTRIES WITH THE HIGHEST MORTALITY RATE FROM PERIPHERAL VASCULAR DISEASE (2013)
TABLE 2 TOP 5 COUNTRIES WITH THE HIGHEST NUMBER OF DIABETICS (AGED 20–79 YEARS), 2015 VS. 2040
TABLE 3 INDICATIVE LIST OF COMPANIES THAT RECEIVED VENTURE CAPITALIST FUNDING FOR THE BLOOD FLOW MEASUREMENT AND MONITORING SEGMENT
TABLE 4 GLOBAL BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
TABLE 5 ULTRASOUND BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
TABLE 6 ULTRASOUND BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
TABLE 7 ULTRASOUND DOPPLER MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
TABLE 8 TRANSIT-TIME FLOW METERS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
TABLE 9 LASER DOPPLER BLOOD FLOW MEASURING DEVICES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
TABLE 10 GLOBAL BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
TABLE 11 BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR NON-INVASIVE APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION)
TABLE 12 BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR NON-INVASIVE APPLICATIONS, BY REGION, 2014–2021 (USD MILLION)
TABLE 13 CARDIOVASCULAR DISEASE APPLICATIONS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
TABLE 14 DIABETES APPLICATIONS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
TABLE 15 GASTROENTEROLOGY APPLICATIONS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
TABLE 16 TUMOR MONITORING APPLICATIONS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
TABLE 17 OTHER NON-INVASIVE APPLICATIONS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
TABLE 18 BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR INVASIVE APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION)
TABLE 19 BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR INVASIVE APPLICATIONS, BY REGION, 2014–2021 (USD MILLION)
TABLE 20 CABG SURGERY APPLICATIONS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
TABLE 21 MICROVASCULAR SURGERY APPLICATIONS MARKET, BY REGION, 2014–2021 (USD MILLION)
TABLE 22 OTHERS INVASIVE APPLICATIONS MARKET, BY REGION, 2014–2021 (USD MILLION)
TABLE 23 BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
TABLE 24 NORTH AMERICA: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
TABLE 25 NORTH AMERICA: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
TABLE 26 NORTH AMERICA: ULTRASOUND BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
TABLE 27 NORTH AMERICA: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
TABLE 28 NORTH AMERICA: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR NON-INVASIVE APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION)
TABLE 29 NORTH AMERICA: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR INVASIVE APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION)
TABLE 30 U.S.: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
TABLE 31 U.S.: ULTRASOUND BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
TABLE 32 U.S.: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
TABLE 33 U.S.: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR NON-INVASIVE APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION)
TABLE 34 U.S.: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR INVASIVE APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION)
TABLE 35 ORGAN TRANSPLANT PROCEDURES PERFORMED IN CANADA (2012–2014)
TABLE 36 CANADA: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
TABLE 37 CANADA: ULTRASOUND BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
TABLE 38 CANADA: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
TABLE 39 CANADA: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR NON-INVASIVE APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION)
TABLE 40 CANADA: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR INVASIVE APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION)
TABLE 41 EUROPE: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
TABLE 42 EUROPE: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
TABLE 43 EUROPE: ULTRASOUND BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
TABLE 44 EUROPE: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
TABLE 45 EUROPE: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR NON-INVASIVE APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION)
TABLE 46 EUROPE: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR INVASIVE APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION)
TABLE 47 EUROPE-5: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
TABLE 48 EUROPE-5: ULTRASOUND BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
TABLE 49 EUROPE-5: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
TABLE 50 EUROPE-5: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR NON-INVASIVE APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION)
TABLE 51 EUROPE-5: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR INVASIVE APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION)
TABLE 52 ROE: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
TABLE 53 ROE: ULTRASOUND BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
TABLE 54 ROE: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
TABLE 55 ROE: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR NON-INVASIVE APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION)
TABLE 56 ROE: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR INVASIVE APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION)
TABLE 57 ASIA-PACIFIC: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
TABLE 58 ASIA-PACIFIC: ULTRASOUND BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
TABLE 59 ASIA-PACIFIC: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
TABLE 60 ASIA-PACIFIC: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR
NON-INVASIVE APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION)
TABLE 61 ASIA-PACIFIC: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR INVASIVE APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION)
TABLE 62 ROW: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
TABLE 63 ROW: ULTRASOUND BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
TABLE 64 ROW: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
TABLE 65 ROW: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR NON-INVASIVE APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION)
TABLE 66 ROW: BLOOD FLOW MEASUREMENT DEVICES MARKET SIZE FOR INVASIVE APPLICATIONS, BY TYPE, 2014–2021 (USD MILLION)
TABLE 67 PRODUCT LAUNCHES, PRODUCT ENHANCEMENTS, AND PRODUCT EXTENSIONS, BY COMPANY (2013–2017)
TABLE 68 COLLABORATIONS, AGREEMENTS, CONTRACTS, JOINT VENTURES, AND PARTNERSHIPS, 2013–2017
TABLE 69 EXPANSIONS AND MARKET DEVELOPMENT (2013–2017)
TABLE 70 OTHER STRATEGIES (2013–2017)
LIST OF FIGURES
FIGURE 1 RESEARCH METHODOLOGY: GLOBAL BLOOD FLOW MEASUREMENT DEVICES MARKET
FIGURE 2 KEY DATA FROM SECONDARY SOURCES
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 SAMPLING FRAME: PRIMARY RESEARCH
FIGURE 5 KEY DATA FROM PRIMARY SOURCES
FIGURE 6 KEY INSIGHTS FROM PRIMARY SOURCES
FIGURE 7 KEY INDUSTRY INSIGHTS
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
FIGURE 9 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 10 RESEARCH DESIGN
FIGURE 11 DATA TRIANGULATION METHODOLOGY
FIGURE 12 GLOBAL BLOOD FLOW MEASUREMENT DEVICES MARKET SHARE, BY APPLICATION (2016)
FIGURE 13 GLOBAL BLOOD FLOW MEASUREMENT DEVICES MARKET, BY PRODUCT (2016 VS. 2021)
FIGURE 14 GLOBAL ULTRASOUND BLOOD FLOW MEASUREMENT DEVICES MARKET, BY TYPE (2016 VS. 2021)
FIGURE 15 ASIA-PACIFIC BLOOD FLOW MEASUREMENT DEVICES MARKET TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 16 GROWING PREVALENCE OF CVD IS A KEY MARKET DRIVER FOR BLOOD FLOW MEASUREMENT DEVICES
FIGURE 17 ULTRASOUND PRODUCTS DOMINATED THE GLOBAL BLOOD FLOW MEASUREMENT DEVICES MARKET IN 2016
FIGURE 18 NONINVASIVE APPLICATIONS TO DOMINATE THE BLOOD FLOW MEASUREMENT DEVICES MARKET DURING THE FORECAST PERIOD
FIGURE 19 ASIA-PACIFIC TO WITNESS THE HIGHEST GROWTH IN THE GLOBAL BLOOD FLOW MEASUREMENT DEVICES MARKET FROM 2016 TO 2021
FIGURE 20 BLOOD FLOW MEASUREMENT DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 21 ULTRASOUND PRODUCTS COMMANDED THE LARGEST SHARE OF THE BLOOD FLOW MEASUREMENT DEVICES MARKET IN 2016
FIGURE 22 ULTRASOUND DOPPLER TO DOMINATE THE ULTRASOUND BLOOD FLOW MEASUREMENT DEVICES MARKET IN 2016
FIGURE 23 NONINVASIVE APPLICATIONS TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET IN 2016
FIGURE 24 CARDIOVASCULAR DISEASE SEGMENT TO ACCOUNT FOR THE LARGEST SHARE IN 2016
FIGURE 25 CORONARY ARTERIAL BYPASS GRAFT APPLICATION SEGMENT TO ACCOUNT FOR THE LARGEST SHARE IN 2016
FIGURE 26 NORTH AMERICA DOMINATED THE BLOOD FLOW MEASUREMENT DEVICES MARKET IN 2016
FIGURE 27 NORTH AMERICA: BLOOD FLOW MEASUREMENT DEVICES MARKET SNAPSHOT
FIGURE 28 EUROPE: BLOOD FLOW MEASUREMENT DEVICES MARKET SNAPSHOT
FIGURE 29 EUROPE: NUMBER OF DIABETICS, BY COUNTRY, 2015 (MILLION CASES)
FIGURE 30 ASIA-PACIFIC: BLOOD FLOW MEASUREMENT DEVICES MARKET SNAPSHOT
FIGURE 31 ROW: BLOOD FLOW MEASUREMENT DEVICES MARKET SNAPSHOT
FIGURE 32 KEY DEVELOPMENTS OF PROMINENT PLAYERS IN THE BLOOD FLOW MEASUREMENT DEVICES MARKET (2013–2017)
FIGURE 33 BATTLE FOR MARKET SHARE: PRODUCT LAUNCHES, PRODUCT ENHANCEMENTS, AND PRODUCT EXTENSIONS FORMED THE KEY GROWTH STRATEGY
FIGURE 34 PRODUCT LAUNCHES, PRODUCT ENHANCEMENTS, AND PRODUCT EXTENSIONS, BY COMPANY (2013–2017)
FIGURE 35 COLLABORATIONS, AGREEMENTS, CONTRACTS, JOINT VENTURES, AND PARTNERSHIPS, BY COMPANY (2013–2017)
FIGURE 36 EXPANSIONS, BY COMPANY (2013–2017)
FIGURE 37 KEY PLAYERS FOCUSING ON OTHER STRATEGIES, BY COMPANY (2013–2017)
FIGURE 38 GEOGRAPHIC REVENUE MIX OF THE TOP 4 MARKET PLAYERS
FIGURE 39 MEDISTIM GROUP: COMPANY SNAPSHOT (2015)
FIGURE 40 GETINGE GROUP: COMPANY SNAPSHOT (2015)
FIGURE 41 DELTEX MEDICAL GROUP PLC: COMPANY SNAPSHOT (2015)
FIGURE 42 COMPUMEDICS LIMITED: COMPANY SNAPSHOT (2016)
FIGURE 1 RESEARCH METHODOLOGY: GLOBAL BLOOD FLOW MEASUREMENT DEVICES MARKET
FIGURE 2 KEY DATA FROM SECONDARY SOURCES
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 SAMPLING FRAME: PRIMARY RESEARCH
FIGURE 5 KEY DATA FROM PRIMARY SOURCES
FIGURE 6 KEY INSIGHTS FROM PRIMARY SOURCES
FIGURE 7 KEY INDUSTRY INSIGHTS
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
FIGURE 9 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 10 RESEARCH DESIGN
FIGURE 11 DATA TRIANGULATION METHODOLOGY
FIGURE 12 GLOBAL BLOOD FLOW MEASUREMENT DEVICES MARKET SHARE, BY APPLICATION (2016)
FIGURE 13 GLOBAL BLOOD FLOW MEASUREMENT DEVICES MARKET, BY PRODUCT (2016 VS. 2021)
FIGURE 14 GLOBAL ULTRASOUND BLOOD FLOW MEASUREMENT DEVICES MARKET, BY TYPE (2016 VS. 2021)
FIGURE 15 ASIA-PACIFIC BLOOD FLOW MEASUREMENT DEVICES MARKET TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 16 GROWING PREVALENCE OF CVD IS A KEY MARKET DRIVER FOR BLOOD FLOW MEASUREMENT DEVICES
FIGURE 17 ULTRASOUND PRODUCTS DOMINATED THE GLOBAL BLOOD FLOW MEASUREMENT DEVICES MARKET IN 2016
FIGURE 18 NONINVASIVE APPLICATIONS TO DOMINATE THE BLOOD FLOW MEASUREMENT DEVICES MARKET DURING THE FORECAST PERIOD
FIGURE 19 ASIA-PACIFIC TO WITNESS THE HIGHEST GROWTH IN THE GLOBAL BLOOD FLOW MEASUREMENT DEVICES MARKET FROM 2016 TO 2021
FIGURE 20 BLOOD FLOW MEASUREMENT DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 21 ULTRASOUND PRODUCTS COMMANDED THE LARGEST SHARE OF THE BLOOD FLOW MEASUREMENT DEVICES MARKET IN 2016
FIGURE 22 ULTRASOUND DOPPLER TO DOMINATE THE ULTRASOUND BLOOD FLOW MEASUREMENT DEVICES MARKET IN 2016
FIGURE 23 NONINVASIVE APPLICATIONS TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET IN 2016
FIGURE 24 CARDIOVASCULAR DISEASE SEGMENT TO ACCOUNT FOR THE LARGEST SHARE IN 2016
FIGURE 25 CORONARY ARTERIAL BYPASS GRAFT APPLICATION SEGMENT TO ACCOUNT FOR THE LARGEST SHARE IN 2016
FIGURE 26 NORTH AMERICA DOMINATED THE BLOOD FLOW MEASUREMENT DEVICES MARKET IN 2016
FIGURE 27 NORTH AMERICA: BLOOD FLOW MEASUREMENT DEVICES MARKET SNAPSHOT
FIGURE 28 EUROPE: BLOOD FLOW MEASUREMENT DEVICES MARKET SNAPSHOT
FIGURE 29 EUROPE: NUMBER OF DIABETICS, BY COUNTRY, 2015 (MILLION CASES)
FIGURE 30 ASIA-PACIFIC: BLOOD FLOW MEASUREMENT DEVICES MARKET SNAPSHOT
FIGURE 31 ROW: BLOOD FLOW MEASUREMENT DEVICES MARKET SNAPSHOT
FIGURE 32 KEY DEVELOPMENTS OF PROMINENT PLAYERS IN THE BLOOD FLOW MEASUREMENT DEVICES MARKET (2013–2017)
FIGURE 33 BATTLE FOR MARKET SHARE: PRODUCT LAUNCHES, PRODUCT ENHANCEMENTS, AND PRODUCT EXTENSIONS FORMED THE KEY GROWTH STRATEGY
FIGURE 34 PRODUCT LAUNCHES, PRODUCT ENHANCEMENTS, AND PRODUCT EXTENSIONS, BY COMPANY (2013–2017)
FIGURE 35 COLLABORATIONS, AGREEMENTS, CONTRACTS, JOINT VENTURES, AND PARTNERSHIPS, BY COMPANY (2013–2017)
FIGURE 36 EXPANSIONS, BY COMPANY (2013–2017)
FIGURE 37 KEY PLAYERS FOCUSING ON OTHER STRATEGIES, BY COMPANY (2013–2017)
FIGURE 38 GEOGRAPHIC REVENUE MIX OF THE TOP 4 MARKET PLAYERS
FIGURE 39 MEDISTIM GROUP: COMPANY SNAPSHOT (2015)
FIGURE 40 GETINGE GROUP: COMPANY SNAPSHOT (2015)
FIGURE 41 DELTEX MEDICAL GROUP PLC: COMPANY SNAPSHOT (2015)
FIGURE 42 COMPUMEDICS LIMITED: COMPANY SNAPSHOT (2016)
